Virginia Heart

Summary

Virginia Heart is a medical facility located in Falls Church, Virginia. This center is recognized for care of Cardiovascular Disease, Atherosclerosis, Stroke, Heart Failure, Atrial Fibrillation and other specialties. Virginia Heart is involved with conducting 22 clinical trials across 38 conditions. There are 1 research doctors associated with this hospital, such as Tariq Haddad.

Top PIs

Clinical Trials running at Virginia Heart

Cardiovascular Disease

Atherosclerosis

Heart Failure

Elevated Lipoprotein

Von Willebrand Disease

Aortic Stenosis

Pelacarsen

for Cardiovascular Disease

This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed either of the double-blind parent studies (CTQJ230A12303 or CTQJ230A12304).

Recruiting

2 awards

Phase 3

Pelacarsen

for Cardiovascular Disease

The purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with ASCVD who have elevated lipoprotein(a) (Lp(a)), and who are on background inclisiran treatment for elevated low-density lipoprotein cholesterol (LDL-C).

Recruiting

1 award

Phase 3

3 criteria

Lepodisiran

for Cardiovascular Disease

This trial is testing lepodisiran, a medication given as an injection under the skin. It targets people with high levels of lipoprotein(a) who have cardiovascular disease or are at risk of heart attack or stroke. The medication works by lowering lipoprotein(a) levels to reduce the risk of these cardiovascular events.

Recruiting

1 award

Phase 3